F05.8
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Adults, consenting patients > 18 years; Cardiac surgery with or without a cardio-pulmonary bypass receiving an aortocoronary bypass or aortic valve operation; ASA I - IV
Exclusion criteria
Exclusion criteria: Absence of consent; Dementia; Failed mini mental test (MMST); Patients with Parkinson's disease; Patients with Alzheimer's disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Correlation between the pre-/perioperative serum acetyl or butyrylcholinesterase concentration and the neuropsychological outcome of the patients. Neuropsychological outcome, ie the occurrence of a delirium, is measured on 1, 2, 3, and 5 postoperative days, using the specific delirium questionnaires Nu-DESC and ICDSC. The acetyl and butyrylcholinesterase concentrations are measured in parallel for this purpose. | — |
Secondary
| Measure | Time frame |
|---|---|
| Modification of serum acetyl- or butyrylcholinesterase concentrations in patients undergoing cardio-vascular surgery; preoperatively, a capillary withdrawal of blood from the fingertip or the ear lobe for the determination of the acetyl- and butyrylcholinesterase is performed, as well as immediately postoperatively on the operating day and in the further course on the first, second, third and fifth postoperative days. Influence of the cardio-pulmonary bypass on the course of acetylcholinesterase and butyrylcholinesterase activity and neuropsychological outcome of the patients. Influence of various surgical procedures (aortocoronary bypass surgery and aortic valve replacement) on cholinesterase activity. | — |
Countries
Germany
Contacts
Klinik für Anästhesiologie, Intensiv-, Palliativ- und Schmerzmedizin; Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil GmbH